Stocks Above the 200-Day Moving Average — Valuation View · Services-Commercial Physical & Biological Research
10 stocks match the Stocks Above the 200-Day Moving Average screen. Stocks trading above their 200-day moving average — a long-term uptrend filter, largest first. Valuation columns. Filtered to Services-Commercial Physical & Biological Research. Updated
Filters2
1–10 of 10
| IQV | IQVIA | $45.3B | 32.74 | 2.73 | 7.29 | 23.29 | — | 271.67 | +2.95% | 119K |
| INCY | Incyte | $25.6B | 17.86 | 4.77 | 4.55 | 7.39 | — | 128.00 | -0.68% | 38K |
| MEDP | Medpace Holdings, Inc. | $16.6B | 33.70 | 5.95 | 38.18 | 32.95 | — | 593.43 | +0.09% | 7K |
| CRL | Charles River Laboratories | $14.0B | -58.72 | 3.50 | 4.93 | 72.91 | — | 293.29 | +0.54% | 36K |
| ABSI | Absci Corp | $1.5B | -12.46 | 332.71 | 6.13 | 13.98 | — | 8.79 | -0.06% | 112K |
| OABI | OmniAb, Inc. | $689M | -15.57 | — | 2.65 | 28.32 | — | 4.74 | -5.77% | 126K |
| NRC | Nrc Health | $470M | 40.51 | 3.36 | 71.76 | 141.25 | 2.6% | 21.25 | +6.23% | 10K |
| MXCT | MAXCYTE, INC. | $131M | -3.66 | — | 0.82 | 8.68 | — | 1.26 | -1.17% | 16K |
| BIAF | bioAffinity Technologies, Inc. | $100M | -6.60 | — | 26.59 | 41.25 | — | 12.37 | +22.48% | 415K |
| ICLR | Icon Plc | — | — | — | — | — | — | 163.59 | +2.36% | 42K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.